FierceBiotech2d
Abbott posts 2024 medical device sales gains following structural heart, CGM launches
For the full calendar of 2024, Abbott recorded sales of $41.95 billion, following the launches last year of a new heart valve ...
MassDevice2d
Abbott sales come up just shy of Q4 expectations on Wall Street, highlights EP growth
Abbott reported fourth-quarter results that missed the consensus sales forecast — but medical device sales remain a bright ...
Why Is Abbott Stock Trading Higher On Thursday?
Abbott's Q4 sales grow 7.2%, missing estimates, but analysts remain upbeat with strong 2025 projections driven by Diabetes ...
Strong Performance and Promising Growth: Rick Wise’s Buy Rating on Abbott Laboratories
Stifel Nicolaus analyst Rick Wise maintained a Buy rating on Abbott Laboratories (ABT – Research Report) yesterday and set a price target of ...
Hosted on MSN2d
Abbott Laboratories Posts 'Middling' Quarter, But Diabetes Devices Shine
Abbott stock traded sideways early Wednesday after the health giant narrowly missed fourth-quarter sales views and reported ...
Abbott Labs Q4 Earnings And Q1 Profit Guidance Lags Street View, Worldwide COVID-19 Testing Sales Fall
Abbott's Q4 sales reached $10.97 billion, with 8.8% organic growth. EPS met expectations at $1.34, driven by strong ...
Abbott Laboratories: Solid Performance in Key Sectors but Hold Rating Due to Mixed Outlook
Morgan Stanley analyst Patrick Wood maintained a Hold rating on Abbott Laboratories (ABT – Research Report) yesterday and set a price target of ...